@article{3164145,
    title = "Novel Inflammatory Biomarkers in Cardiovascular Therapeutics",
    author = "Tsigkou, Vicky and Siasos, Gerasimos and Oikonomou, Evangelos and and Zaromitidou, Marina and Latsios, George and Vavuranakis, Manolis and and Deftereos, Spyridon and Cleman, Michael W. and Kokkou, Eleni and and Limberi, Maria and Dimitropoulos, Stathis and Zografos, Thodoris and and Marinaki, Smaragdi and Stefanadis, Christodoulos and Tousoulis, Dimitris",
    journal = "Current Medicinal Chemistry",
    year = "2015",
    volume = "22",
    number = "23",
    pages = "2773-2785",
    publisher = "BENTHAM SCIENCE PUBL LTD",
    issn = "0929-8673",
    doi = "10.2174/0929867322666150429110124",
    keywords = "Atherosclerosis; biomarkers; cardiovascular diseases; coronary artery
disease; heart failure; hypertension; inflammation; peripheral artery
disease; stroke",
    abstract = "Inflammation has been established as an important determinant of
cardiovascular disease progression. Currently, clinical examination,
laboratory and imaging tests are invaluable for the diagnosis, prognosis
and disease monitoring. Novel inflammatory biomarkers are also used to
better restratify patients in risk groups but their potential to guide
treatment decisions and management of patients has not been extensively
evaluated. Therefore, in this review article we present the most recent
data concerning the use of inflammatory biomarkers in cardiovascular
therapeutics."
}